ArticlePharmaceutics2024

Impact of V9302, a Competitive Antagonist of Transmembrane Glutamine Flux on Reversal of Resistance in Breast Cancer Cell Lines.

Nikoletta Szemerédi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.